Mohsen Moghadami
Overview
Explore the profile of Mohsen Moghadami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
1174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yazdanpanah S, Shafiekhani M, Ahmadi M, Zare Z, Nikoupour H, Arabsheybani S, et al.
Med Mycol
. 2024 Dec;
63(1).
PMID: 39663216
Fungal infections are serious complications after solid organ transplantation, with high mortality and morbidity. Given the importance of the local epidemiological data and also extensive prophylactic regimens in solid organ...
2.
Heidari M, Yaghobi R, Moghadami M, Zand F, Fallahi M, Pourfathollah A, et al.
Cell Mol Biol (Noisy-le-grand)
. 2024 Oct;
70(9):1-9.
PMID: 39380285
Following the outbreak of COVID-19, several immunotherapy methods were used to modulate the immune responses of patients. In this study, we aimed to evaluate the immune response to COVID-19 in...
3.
Omidifar N, Nili-Ahmadabadi A, Nakhostin-Ansari A, Bagheri Lankarani K, Moghadami M, Mousavi S, et al.
Environ Sci Pollut Res Int
. 2024 Sep;
31(47):58202.
PMID: 39289267
No abstract available.
4.
Shahriarirad S, Asmarian N, Shahriarirad R, Moghadami M, Askarian M, Hashemizadeh Fard Haghighi L, et al.
Iran J Med Sci
. 2024 Apr;
49(4):247-258.
PMID: 38680224
Background: Even though a few years have passed since the coronavirus disease 2019 (COVID-19) outbreak, information regarding certain aspects of the disease, such as post-infection immunity, is still quite limited....
5.
Ghahramani S, Moghadami M, Omidifar N, Tabatabaei S, Sayari M, Bagheri Lankarani K
Brain Behav
. 2024 Feb;
14(1):e3384.
PMID: 38376037
Background And Aims: Faculty members confront a variety of obstacles over time, the most recent of which is the coronavirus disease 2019 pandemic, which may increase their vulnerability to burnout...
6.
Hosseini Z, Azizi K, Moghadami M, Hassaniazad M, Shafiei R, Rezaee E, et al.
J Arthropod Borne Dis
. 2023 Oct;
17(2):128-137.
PMID: 37822760
Background: Asymptomatic malaria is a major challenge to be addressed in the implementation of the malaria elimination program. The main goal of the malaria surveillance system in the elimination phase...
7.
Mohraz M, Vahdat K, Ghamari S, Abbasi-Kangevari M, Ghasemi E, Ghabdian Y, et al.
BMJ
. 2023 Sep;
382:e070464.
PMID: 37734752
Objective: To report the efficacy, safety, and exploratory immunogenicity findings of two 5 µg doses of the BIV1-CovIran vaccine. Design: Randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial....
8.
Ashrafi F, Mohseni M, Beheshtian M, Fattahi Z, Ghodratpour F, Keshavarzi F, et al.
Arch Iran Med
. 2023 Aug;
26(2):69-75.
PMID: 37543926
Background: Global real-time monitoring of SARS-CoV-2 variants is crucial to controlling the COVID-19 outbreak. The purpose of this study was to set up a Sanger-based platform for massive SARS-CoV-2 variant...
9.
Fattahi Z, Mohseni M, Beheshtian M, Jafarpour A, Jalalvand K, Keshavarzi F, et al.
Arch Iran Med
. 2023 Aug;
25(8):508-522.
PMID: 37543873
Background: Complete SARS-CoV-2 genome sequencing in the early phase of the outbreak in Iran showed two independent viral entries. Subsequently, as part of a genome surveillance project, we aimed to...
10.
Shafiekhani M, Mirjalili M, Gholami S, Vatankhah P, Roozbeh J, Mehrdad G, et al.
Adv Exp Med Biol
. 2023 Jun;
1412:357-374.
PMID: 37378777
BackgroundImmunocompromised patients have lower seroconversion rate in response to COVID-19 vaccination. The aim of this study is to evaluate the humoral immune response with short-term clinical outcomes in solid organ...